dc.contributor.author | Humphries, MP | |
dc.contributor.author | Maxwell, P | |
dc.contributor.author | Salto-Tellez, M | |
dc.date.accessioned | 2021-05-24T08:21:43Z | |
dc.date.available | 2021-05-24T08:21:43Z | |
dc.date.issued | 2021-01-29 | |
dc.identifier.citation | Computational and structural biotechnology journal, 2021, 19 pp. 852 - 859 | |
dc.identifier.issn | 2001-0370 | |
dc.identifier.uri | https://repository.icr.ac.uk/handle/internal/4574 | |
dc.identifier.eissn | 2001-0370 | |
dc.identifier.doi | 10.1016/j.csbj.2021.01.022 | |
dc.description.abstract | QuPath, originally created at the Centre for Cancer Research & Cell Biology at Queen's University Belfast as part of a research programme in digital pathology (DP) funded by Invest Northern Ireland and Cancer Research UK, is arguably the most wildly used image analysis software program in the world. On the back of the explosion of DP and a need to comprehensively visualise and analyse whole slides images (WSI), QuPath was developed to address the many needs associated with tissue based image analysis; these were several fold and, predominantly, translational in nature: from the requirement to visualise images containing billions of pixels from files several GBs in size, to the demand for high-throughput reproducible analysis, which the paradigm of routine visual pathological assessment continues to struggle to deliver. Resultantly, large-scale biomarker quantification must increasingly be augmented with DP. Here we highlight the impact of the open source Quantitative Pathology & Bioimage Analysis DP system since its inception, by discussing the scope of scientific research in which QuPath has been cited, as the system of choice for researchers. | |
dc.format | Electronic-eCollection | |
dc.format.extent | 852 - 859 | |
dc.language | eng | |
dc.language.iso | eng | |
dc.publisher | ELSEVIER | |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0 | |
dc.title | QuPath: The global impact of an open source digital pathology system. | |
dc.type | Journal Article | |
dcterms.dateAccepted | 2021-01-14 | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | 10.1016/j.csbj.2021.01.022 | |
rioxxterms.licenseref.uri | https://creativecommons.org/licenses/by/4.0 | |
rioxxterms.licenseref.startdate | 2021-01-21 | |
rioxxterms.type | Journal Article/Review | |
dc.relation.isPartOf | Computational and structural biotechnology journal | |
pubs.notes | Not known | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Integrated Pathology | |
pubs.organisational-group | /ICR | |
pubs.organisational-group | /ICR/Primary Group | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology | |
pubs.organisational-group | /ICR/Primary Group/ICR Divisions/Molecular Pathology/Integrated Pathology | |
pubs.publication-status | Published | |
pubs.volume | 19 | |
pubs.embargo.terms | Not known | |
icr.researchteam | Integrated Pathology | |
icr.researchteam | Integrated Pathology | |
dc.contributor.icrauthor | Salto-Tellez, Manuel | |